English
Polski
Español
українська
Is plasmapheresis effective in rheumatologic emergencies?
Is plasmapheresis an effective treatment in rheumatologic emergencies?
2018-12-20
Is plasmapheresis an effective treatment in rheumatologic emergencies?
Secondary amyloidosis is a potentially fatal complication of chronic inflammatory diseases. When should it be suspected?
Is frailty associated with a risk of fractures? Is quantitative assessment of frailty possible?
When should we use plasmapheresis in rheumatologic emergencies?
How can we predict osteoporotic fractures in an elderly patient? What are the best tools to diagnose osteoporosis that help in decision-making?
Can biologic treatment be restarted in a patient who developed tuberculosis (TB) while on anti–tumor necrosis factor (TNF) treatment? Can we use anti-TNF agents again in such patients?
How should we manage a patient with latent tuberculosis (TB) infection before starting biologic treatment?
Is osteoporosis caused by long-term use of strong opioids a significant clinical problem?
What is the risk of tuberculosis (TB) during biologic treatment with agents other than tumor necrosis factor (TNF)–alpha inhibitors?
What should be the initial management in rheumatologic emergencies? Which patients should be transported to the ICU?
